Screener
Emergent Biosolutions EBS Billed Contract Receivables
Billed Contract Receivables at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:BilledContractReceivables.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's billed contract receivables?
- Emergent Biosolutions (EBS) reported billed contract receivables of $170M in Q2 2026.
- How has Emergent Biosolutions's billed contract receivables changed year-over-year?
- Emergent Biosolutions's billed contract receivables increased by 192.1% year-over-year, from $58.2M to $170M.
- What is the long-term trend for Emergent Biosolutions's billed contract receivables?
- Over 5 years (2020 to 2025), Emergent Biosolutions's billed contract receivables has grown at a -17.3% compound annual growth rate (CAGR), from $172.7M to $66.8M.
- What does billed contract receivables mean?
- Billed Contract Receivables as reported by Emergent Biosolutions, Inc..
Ask your AI about Emergent Biosolutions's billed contract receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude